Letter: Hepatitis-B antigen: immunological relationship to LP-X, the abnormal plasma-lipoprotein of obstructive jaundice

Methodology Used in DNA-Based Prophylactic and Therapeutic Immunization Against Hepatitis B Virus in Chimpanzees.

Methods in molecular medicine·2011

Development of the International Consortium for Blood Safety (ICBS) HCV panels.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2008

Schistosoma infection inhibits cellular immune responses to core HCV peptides.

Parasite immunology·2005

Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation.

Antimicrobial agents and chemotherapy·2004

Hepatitis C virus replication kinetics in chimpanzees with self-limited and chronic infections.

Journal of viral hepatitis·2004

Perspectives on prophylactic and therapeutic immunization against hepatitis B and C viruses.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2002

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Lancet (London, England)·2026

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Scleroderma-Like Phenotype in a Patient With Transthyretin Cardiac Amyloidosis and Acromegaly: A Triple Diagnostic Challenge.

Cureus·2026

In-vitro exposure to mercury chloride, with and without n-3 long chain polyunsaturated fatty acids, on the Th17-associated immune response in peripheral blood mononuclear cells from systemic lupus erythematosus patients.

Journal of immunotoxicology·2026

Mesenchymal Stem Cell Therapy for Multiple Sclerosis: Harnessing Immunological Properties.

Biomolecules & therapeutics·2026

Molecular underpinnings of rheumatic diseases and emerging therapeutic concepts.

Nature·2026

Adaptive immune plasticity in MASH: Functional states, pathological consequences, and regulatory mechanisms.

Hepatology communications·2026

Imaging of myositis: An overview and update.

Seminars in nuclear medicine·2026

Letter: Hepatitis-B antigen: immunological relationship to LP-X, the abnormal plasma-lipoprotein of obstructive jaundice

Related Experiment Videos

Related Concept Videos

Methodology Used in DNA-Based Prophylactic and Therapeutic Immunization Against Hepatitis B Virus in Chimpanzees.

Development of the International Consortium for Blood Safety (ICBS) HCV panels.

Schistosoma infection inhibits cellular immune responses to core HCV peptides.

Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation.

Hepatitis C virus replication kinetics in chimpanzees with self-limited and chronic infections.

Perspectives on prophylactic and therapeutic immunization against hepatitis B and C viruses.

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Scleroderma-Like Phenotype in a Patient With Transthyretin Cardiac Amyloidosis and Acromegaly: A Triple Diagnostic Challenge.

In-vitro exposure to mercury chloride, with and without n-3 long chain polyunsaturated fatty acids, on the Th17-associated immune response in peripheral blood mononuclear cells from systemic lupus erythematosus patients.

Mesenchymal Stem Cell Therapy for Multiple Sclerosis: Harnessing Immunological Properties.

Molecular underpinnings of rheumatic diseases and emerging therapeutic concepts.

Adaptive immune plasticity in MASH: Functional states, pathological consequences, and regulatory mechanisms.

Imaging of myositis: An overview and update.

Letter: Hepatitis-B antigen: immunological relationship to LP-X, the abnormal plasma-lipoprotein of obstructive jaundice

Related Experiment Videos

Related Concept Videos

Related Articles